CSF or Serum Neurofilament Light Added to α‐Synuclein Panel Discriminates Parkinson's From Controls-Reference-Cited by-同舟云学术

CSF or Serum Neurofilament Light Added to α‐Synuclein Panel Discriminates Parkinson's From Controls

Published:2019-11-18 Issue:2 Volume:35 Page:288-295
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord

Author:

Oosterveld Linda P.¹,Verberk Inge M.W.²,Majbour Nour K.³,El‐Agnaf Omar M.³,Weinstein Henry C.⁴⁵,Berendse Henk W.⁴,Teunissen Charlotte E.²,Berg Wilma D.J.¹

Affiliation:

1. Department of Anatomy and Neurosciences, Section Clinical Anatomy and Biobanking, Amsterdam Neuroscience Amsterdam UMC, Vrije Universiteit Amsterdam Amsterdam Netherlands

2. Department of Clinical Chemistry, Neurochemistry Laboratory, Amsterdam Neuroscience Amsterdam UMC, Vrije Universiteit Amsterdam Amsterdam Netherlands

3. Neurological Disorders Research Center Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation Doha Qatar

4. Department of Neurology, Amsterdam Neuroscience Amsterdam UMC, Vrije Universiteit Amsterdam Amsterdam Netherlands

5. Department of Neurology OLVG Amsterdam The Netherlands

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mds.27897

Reference50 articles.

1. Discovery, validation and optimization of cerebrospinal fluid biomarkers for use in Parkinson’s disease

2. Cerebrospinal fluid biomarkers in Parkinson disease

3. Cerebrospinal fluid and plasma clusterin levels in Parkinson's disease